▶ 調査レポート

関節リウマチ診断検査の世界市場

• 英文タイトル:Global Market Study on Rheumatoid Arthritis Diagnosis Tests: Rheumatoid Factor (RF) Serology Tests Segment to Significantly Contribute to Global Market Growth in the Coming Years

Persistence Market Researchが調査・発行した産業分析レポートです。関節リウマチ診断検査の世界市場 / Global Market Study on Rheumatoid Arthritis Diagnosis Tests: Rheumatoid Factor (RF) Serology Tests Segment to Significantly Contribute to Global Market Growth in the Coming Years / B-PMR-012資料のイメージです。• レポートコード:B-PMR-012
• 出版社/出版日:Persistence Market Research / 2018年1月31日
• レポート形態:英文、PDF、216ページ
• 納品方法:Eメール(受注後2営業日)
• 産業分類:医療・バイオ
• 販売価格(消費税別)
  Individual(1名、印刷不可)¥524,300 (USD4,900)▷ お問い合わせ
  Multi User(5名)¥813,200 (USD7,600)▷ お問い合わせ
  Corporate User¥1,134,200 (USD10,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査レポートでは、関節リウマチ診断検査の世界市場について調査・分析し、関連企業情報、産業分析、関節リウマチ診断検査の世界市場規模、市場動向、セグメント別市場分析、地域別市場規模(欧州、アメリカ、アジアなど)、市場予測データを含め、以下の構成でお届けいたします。

This Persistence Market Research (PMR) report examines the rheumatoid arthritis market performance in terms of value and volume contribution. The report includes key trends, drivers, restraints, and opportunities influencing growth of the global rheumatoid arthritis market over forecast period (2016–2027). Impact analysis of key growth drivers and restraints based on the weighted average model are included in this report to better equip clients with crystal clear decision-making insights. Various types of kits used to ascertain amount of substance in samples across hospitals, diagnostic laboratories, ambulatory surgical centers have been considered in this report.
The Rheumatoid Arthritis Diagnosis Tests Market segmented as follows:

By Test Type
Serology Tests
Monitoring RA Treatment Efficiency Tests
By End User
Diagnostic Laboratories
Ambulatory Surgical Centers
Hospitals
By Region
North America
Latin America
Europe
Asia Pacific (APAC)
Middle East and Africa (MEA)
This report covers the global rheumatoid arthritis diagnosis tests market performance in terms of revenue contribution from various segments. This section also includes PMR analysis of key trends, drivers, restraints, and opportunities, which are influencing the growth of the global rheumatoid arthritis diagnosis tests market.

The global rheumatoid arthritis diagnosis tests market report begins with an overview of the global rheumatoid arthritis diagnosis tests market. This section also underlines factors influencing growth of the global rheumatoid arthritis diagnosis tests market along with detailing of the key trends, drivers, restraints, opportunity and regulations. Impact analysis of key regional growth drivers and restraints based on the weighted average model along with key region-specific trends is included in report to better equip clients with information and hidden insights.

The global rheumatoid arthritis diagnosis tests market is segmented on the basis of test type, end user and region. By test type, the global rheumatoid arthritis diagnosis tests market is segmented into serology test and monitoring RA treatment efficiency monitoring tests. Serology test segment is further sub-segmented into erythrocyte sedimentation rate (ESR), rheumatoid factor (RF), anti-cyclic citrullinated peptide (anti-CCP), antinuclear antibody (ANA), uric acid test, and other tests. RA treatment efficiency monitoring tests segment is further sub-segmented into Salicylate Level Count, Muscle Enzyme Tests (CPK, Aldolase), and Creatinine Test. A detailed analysis has been provided for every segment in terms of market size, Y-o-Y growth rate, absolute $ opportunity, market attractive index.

By end user, the global rheumatoid arthritis diagnosis tests market is segmented into hospital, diagnostic laboratories, and ambulatory surgical centers. Diagnostic laboratory segment is further sub-segmented into private laboratories and public laboratories. The next section of the report highlights the growth trends of the rheumatoid arthritis diagnosis tests market by region. It provides a market outlook for 2012–2027 and sets the forecast within the context of the rheumatoid arthritis diagnosis tests market. The study discusses key regional trends contributing to growth of the rheumatoid arthritis diagnosis tests market worldwide, as well as analyses the extent to which drivers are influencing this market in each region. Key regions assessed in this report include North America, Latin America, Europe, Asia Pacific and MEA. APAC region is expected to emerge dominant and most attractive over the forecast period.

The above sections – test type, end user and region – evaluate the present scenario and growth prospects of the rheumatoid arthritis diagnosis tests market for the period 2012–2027. We have considered 2016 as the base year and provided data for the forecast period.

The final chapter in the report covers analysis on key competitors involved in this market. Detailed company profiles include company-specific long-term and short-term strategies, key offerings and recent developments in the rheumatoid arthritis diagnosis tests market.

レポート目次

Table of Content

1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. PMR Analysis and Recommendations
1.4. Wheel of Fortune

2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition

3. Rheumatoid Arthritis Diagnosis Tests Market Opportunity Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
3.3. Pricing Analysis, by Region
3.3.1. Product Pricing Analysis
3.3.2. Service Pricing Analysis

4. North America Rheumatoid Arthritis Diagnosis Tests Market Analysis 2012–2016 and Forecast 2017–2027
4.1. Introduction
4.2. Regional Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Trends
4.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
4.3.1. U.S.
4.3.2. Canada
4.4. Market Size (US$ Mn) Forecast By Country, 2017–2027
4.4.1. U.S.
4.4.2. Canada
4.5. Historical Market Size (US$ Mn) Trend Analysis By Test Type, 2012–2016
4.5.1. Serology Test Type
4.5.1.1. Erythrocyte Sedimentation Rate (ESR) Test Type
4.5.1.2. Rheumatoid Factor (RF) Test Type
4.5.1.3. Anti–cyclic Citrullinated Peptide (anti–CCP) Test Type
4.5.1.4. Antinuclear Antibody (ANA) Test Type
4.5.1.5. Uric Acid Test Type
4.5.1.6. Other Test Type
4.5.2. Monitoring RA Treatment Efficiency Tests
4.5.2.1. Salicylate Level Count Test Type
4.5.2.2. Muscle Enzyme Tests Type
4.5.2.3. Creatinine Test Type
4.6. Market Size (US$ Mn) Forecast By Test Type, 2017–2027
4.6.1. Serology Test Type
4.6.1.1. Erythrocyte Sedimentation Rate (ESR) Test Type
4.6.1.2. Rheumatoid Factor (RF) Test Type
4.6.1.3. Anti–cyclic Citrullinated Peptide (anti–CCP) Test Type
4.6.1.4. Antinuclear Antibody (ANA) Test Type
4.6.1.5. Uric Acid Test Type
4.6.1.6. Other Test Type
4.6.2. Monitoring RA Treatment Efficiency Tests
4.6.2.1. Salicylate Level Count Test Type
4.6.2.2. Muscle Enzyme Tests Type
4.6.2.3. Creatinine Test Type
4.7. Historical Market Size (US$ Mn) Trend Analysis By End Users, 2012–2016
4.7.1. Diagnostics laboratories
4.7.1.1. Public Laboratories
4.7.1.2. Private Laboratories
4.7.2. Ambulatory Surgical Centers
4.7.3. Hospitals
4.8. Market Size (US$ Mn) Forecast By End Users, 2017–2027
4.8.1. Diagnostics laboratories
4.8.1.1. Public Laboratories
4.8.1.2. Private Laboratories
4.8.2. Ambulatory Surgical Centers
4.8.3. Hospitals
4.9. Drivers and Restraints: Impact Analysis
4.10. Market Attractiveness Analysis
4.10.1. By Country
4.10.2. By Test Type
4.10.3. By End User
4.11. Key Representative Market Participants
4.12. Market Presence (Intensity Map)

5. Latin America Rheumatoid Arthritis Diagnosis Tests Market Analysis 2012–2016 and Forecast 2017–2027
5.1. Introduction
5.2. Regional Market Dynamics
5.2.1. Drivers
5.2.2. Restraints
5.2.3. Trends
5.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
5.3.1. Brazil
5.3.2. Mexico
5.3.3. Rest of Latin America
5.4. Market Size (US$ Mn) Forecast By Country, 2017–2027
5.4.1. Brazil
5.4.2. Mexico
5.4.3. Rest of Latin America
5.5. Historical Market Size (US$ Mn) Trend Analysis By Test Type, 2012–2016
5.5.1. Serology Test Type
5.5.1.1. Erythrocyte Sedimentation Rate (ESR) Test Type
5.5.1.2. Rheumatoid Factor (RF) Test Type
5.5.1.3. Anti–cyclic Citrullinated Peptide (anti–CCP) Test Type
5.5.1.4. Antinuclear Antibody (ANA) Test Type
5.5.1.5. Uric Acid Test Type
5.5.1.6. Other Test Type
5.5.2. Monitoring RA Treatment Efficiency Tests
5.5.2.1. Salicylate Level Count Test Type
5.5.2.2. Muscle Enzyme Tests Type
5.5.2.3. Creatinine Test Type
5.6. Market Size (US$ Mn) Forecast By Test Type, 2017–2027
5.6.1. Serology Test Type
5.6.1.1. Erythrocyte Sedimentation Rate (ESR) Test Type
5.6.1.2. Rheumatoid Factor (RF) Test Type
5.6.1.3. Anti–cyclic Citrullinated Peptide (anti–CCP) Test Type
5.6.1.4. Antinuclear Antibody (ANA) Test Type
5.6.1.5. Uric Acid Test Type
5.6.1.6. Other Test Type
5.6.2. Monitoring RA Treatment Efficiency Tests
5.6.2.1. Salicylate Level Count Test Type
5.6.2.2. Muscle Enzyme Tests Type
5.6.2.3. Creatinine Test Type
5.7. Historical Market Size (US$ Mn) Trend Analysis By End Users, 2012–2016
5.7.1. Diagnostics laboratories
5.7.1.1. Public Laboratories
5.7.1.2. Private Laboratories
5.7.2. Ambulatory Surgical Centers
5.7.3. Hospitals
5.8. Market Size (US$ Mn) Forecast By End Users, 2017–2027
5.8.1. Diagnostics laboratories
5.8.1.1. Public Laboratories
5.8.1.2. Private Laboratories
5.8.2. Ambulatory Surgical Centers
5.8.3. Hospitals
5.9. Drivers and Restraints: Impact Analysis
5.10. Market Attractiveness Analysis
5.10.1. By Country
5.10.2. By Test Type
5.10.3. By End User
5.11. Key Representative Market Participants
5.12. Market Presence (Intensity Map)

6. Europe Rheumatoid Arthritis Diagnosis Tests Market Analysis 2012–2016 and Forecast 2017–2027
6.1. Introduction
6.2. Regional Market Dynamics
6.2.1. Drivers
6.2.2. Restraints
6.2.3. Trends
6.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
6.3.1. Germany
6.3.2. U.K.
6.3.3. France
6.3.4. Italy
6.3.5. Spain
6.3.6. Russia
6.3.7. Rest of Europe
6.4. Market Size (US$ Mn) Forecast By Country, 2017–2027
6.4.1. Germany
6.4.2. U.K.
6.4.3. France
6.4.4. Italy
6.4.5. Spain
6.4.6. Russia
6.4.7. Rest of Europe
6.5. Historical Market Size (US$ Mn) Trend Analysis By Test Type, 2012–2016
6.5.1. Serology Test Type
6.5.1.1. Erythrocyte Sedimentation Rate (ESR) Test Type
6.5.1.2. Rheumatoid Factor (RF) Test Type
6.5.1.3. Anti–cyclic Citrullinated Peptide (anti–CCP) Test Type
6.5.1.4. Antinuclear Antibody (ANA) Test Type
6.5.1.5. Uric Acid Test Type
6.5.1.6. Other Test Type
6.5.2. Monitoring RA Treatment Efficiency Tests
6.5.2.1. Salicylate Level Count Test Type
6.5.2.2. Muscle Enzyme Tests Type
6.5.2.3. Creatinine Test Type
6.6. Market Size (US$ Mn) Forecast By Test Type, 2017–2027
6.6.1. Serology Test Type
6.6.1.1. Erythrocyte Sedimentation Rate (ESR) Test Type
6.6.1.2. Rheumatoid Factor (RF) Test Type
6.6.1.3. Anti–cyclic Citrullinated Peptide (anti–CCP) Test Type
6.6.1.4. Antinuclear Antibody (ANA) Test Type
6.6.1.5. Uric Acid Test Type
6.6.1.6. Other Test Type
6.6.2. RA Treatment Efficiency Tests
6.6.2.1. Salicylate Level Count Test Type
6.6.2.2. Muscle Enzyme Tests Type
6.6.2.3. Creatinine Test Type
6.7. Historical Market Size (US$ Mn) Trend Analysis By End Users, 2012–2016
6.7.1. Diagnostics laboratories
6.7.1.1. Public Laboratories
6.7.1.2. Private Laboratories
6.7.2. Ambulatory Surgical Centers
6.7.3. Hospitals
6.8. Market Size (US$ Mn) Forecast By End Users, 2017–2027
6.8.1. Diagnostics laboratories
6.8.1.1. Public Laboratories
6.8.1.2. Private Laboratories
6.8.2. Ambulatory Surgical Centers
6.8.3. Hospitals
6.9. Drivers and Restraints: Impact Analysis
6.10. Market Attractiveness Analysis
6.10.1. By Country
6.10.2. By Test Type
6.10.3. By End User
6.11. Key Representative Market Participants
6.12. Market Presence (Intensity Map)

7. Asia Pacific Rheumatoid Arthritis Diagnosis Tests Market Analysis 2012–2016 and Forecast 2017–2027
7.1. Introduction
7.2. Regional Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Trends
7.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
7.3.1. China
7.3.2. Japan
7.3.3. India
7.3.4. ASEAN
7.3.5. Australia and New Zealand
7.3.6. Rest of Asia Pacific
7.4. Market Size (US$ Mn) Forecast By Country, 2017–2027
7.4.1. China
7.4.2. Japan
7.4.3. India
7.4.4. ASEAN
7.4.5. Australia and New Zealand
7.4.6. Rest of Asia Pacific
7.5. Historical Market Size (US$ Mn) Trend Analysis By Test Type, 2012–2016
7.5.1. Serology Test Type
7.5.1.1. Erythrocyte Sedimentation Rate (ESR) Test Type
7.5.1.2. Rheumatoid Factor (RF) Test Type
7.5.1.3. Anti–cyclic Citrullinated Peptide (anti–CCP) Test Type
7.5.1.4. Antinuclear Antibody (ANA) Test Type
7.5.1.5. Uric Acid Test Type
7.5.1.6. Other Test Type
7.5.2. Monitoring RA Treatment Efficiency Tests
7.5.2.1. Salicylate Level Count Test Type
7.5.2.2. Muscle Enzyme Tests Type
7.5.2.3. Creatinine Test Type
7.6. Market Size (US$ Mn) Forecast By Test Type, 2017–2027
7.6.1. Serology Test Type
7.6.1.1. Erythrocyte Sedimentation Rate (ESR) Test Type
7.6.1.2. Rheumatoid Factor (RF) Test Type
7.6.1.3. Anti–cyclic Citrullinated Peptide (anti–CCP) Test Type
7.6.1.4. Antinuclear Antibody (ANA) Test Type
7.6.1.5. Uric Acid Test Type
7.6.1.6. Other Test Type
7.6.2. Monitoring RA Treatment Efficiency Tests
7.6.2.1. Salicylate Level Count Test Type
7.6.2.2. Muscle Enzyme Tests Type
7.6.2.3. Creatinine Test Type
7.7. Historical Market Size (US$ Mn) Trend Analysis By End Users, 2012–2016
7.7.1. Hospitals
7.7.2. Diagnostics laboratories
7.7.2.1. Public Laboratories
7.7.2.2. Private Laboratories
7.7.3. Ambulatory Surgical Centers
7.8. Market Size (US$ Mn) Forecast By End Users, 2017–2027
7.8.1. Hospitals
7.8.2. Diagnostics laboratories
7.8.2.1. Public Laboratories
7.8.2.2. Private Laboratories
7.8.3. Ambulatory Surgical Centers
7.9. Drivers and Restraints: Impact Analysis
7.10. Market Attractiveness Analysis
7.10.1. By Country
7.10.2. By Test Type
7.10.3. By End User
7.11. Key Representative Market Participants
7.12. Market Presence (Intensity Map)

8. Middle East & Africa Rheumatoid Arthritis Diagnosis Tests Market Analysis 2012–2016 and Forecast 2017–2027
8.1. Introduction
8.2. Regional Market Dynamics
8.2.1. Drivers
8.2.2. Restraints
8.2.3. Trends
8.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
8.3.1. GCC Countries
8.3.2. South Africa
8.3.3. North Africa
8.3.4. Rest of MEA
8.4. Market Size (US$ Mn) Forecast By Country, 2017–2027
8.4.1. GCC Countries
8.4.2. South Africa
8.4.3. North Africa
8.4.4. Rest of MEA
8.5. Historical Market Size (US$ Mn) Trend Analysis By Test Type, 2012–2016
8.5.1. Serology Test Type
8.5.1.1. Erythrocyte Sedimentation Rate (ESR) Test Type
8.5.1.2. Rheumatoid Factor (RF) Test Type
8.5.1.3. Anti–cyclic Citrullinated Peptide (anti–CCP) Test Type
8.5.1.4. Antinuclear Antibody (ANA) Test Type
8.5.1.5. Uric Acid Test Type
8.5.1.6. Other Test Type
8.5.2. Monitoring RA Treatment Efficiency Tests
8.5.2.1. Salicylate Level Count Test Type
8.5.2.2. Muscle Enzyme Tests Type
8.5.2.3. Creatinine Test Type
8.6. Market Size (US$ Mn) Forecast By Test Type, 2017–2027
8.6.1. Serology Test Type
8.6.1.1. Erythrocyte Sedimentation Rate (ESR) Test Type
8.6.1.2. Rheumatoid Factor (RF) Test Type
8.6.1.3. Anti–cyclic Citrullinated Peptide (anti–CCP) Test Type
8.6.1.4. Antinuclear Antibody (ANA) Test Type
8.6.1.5. Uric Acid Test Type
8.6.1.6. Other Test Type
8.6.2. Monitoring RA Treatment Efficiency Tests
8.6.2.1. Salicylate Level Count Test Type
8.6.2.2. Muscle Enzyme Tests Type
8.6.2.3. Creatinine Test Type
8.7. Historical Market Size (US$ Mn) Trend Analysis By End Users, 2012–2016
8.7.1. Diagnostics laboratories
8.7.1.1. Public Laboratories
8.7.1.2. Private Laboratories
8.7.2. Ambulatory Surgical Centers
8.7.3. Hospitals
8.8. Market Size (US$ Mn) Forecast By End Users, 2017–2027
8.8.1. Diagnostics laboratories
8.8.1.1. Public Laboratories
8.8.1.2. Private Laboratories
8.8.2. Ambulatory Surgical Centers
8.8.3. Hospitals
8.9. Drivers and Restraints: Impact Analysis
8.10. Market Attractiveness Analysis
8.10.1. By Country
8.10.2. By Test Type
8.10.3. By End User
8.11. Key Representative Market Participants
8.12. Market Presence (Intensity Map)

9. Forecast Factors: Relevance and Impact

10. Forecast Assumptions

11. Competition Landscape
11.1. Market Structure
11.2. Competition Intensity Mapping by Market Taxonomy
11.3. Competition Dashboard
11.4. Company Profiles (Details – Overview, Financials, Strategy, SWOT, Recent Developments)
11.4.1. Abbott Laboratories, Inc.
11.4.2. Antibodies Inc.
11.4.3. Beckman Coulter, Inc.
11.4.4. Euro Diagnostica AB
11.4.5. F. Hoffmann-La Roche Ltd.
11.4.6. Qiagen N.V.
11.4.7. Siemens Healthcare GmbH
11.4.8. Thermo Fisher Scientific, Inc.
11.4.9. Bio Rad Laboratories Inc.
11.4.10. Genway Biotech, Inc. (Aviva Systems Biology Corp.)

12. Global Rheumatoid Arthritis Diagnosis Tests Market Analysis 2012–2016 and Forecast 2017–2027, By Region
12.1. Introduction/Key Findings
12.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2012–2016
12.2.1. North America
12.2.2. Latin America
12.2.3. Europe
12.2.4. Asia Pacific
12.2.5. Middle East & Africa
12.3. Market Size (US$ Mn) Forecast By Region, 2017–2027
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. Asia Pacific
12.3.5. Middle East & Africa
12.4. Market Attractiveness Analysis By Region

13. Global Rheumatoid Arthritis Diagnosis Tests Market Analysis 2012–2016 and Forecast 2017–2027, By Test Type
13.1. Introduction/Key Findings
13.2. Historical Market Size (US$ Mn) Trend Analysis By Test Type, 2012–2016
13.2.1. Serology Test Type
13.2.1.1. Erythrocyte Sedimentation Rate (ESR) Test Type
13.2.1.2. Rheumatoid Factor (RF) Test Type
13.2.1.3. Anti–cyclic Citrullinated Peptide (anti–CCP) Test Type
13.2.1.4. Antinuclear Antibody (ANA) Test Type
13.2.1.5. Uric Acid Test Type
13.2.1.6. Other Test Type
13.2.2. Monitoring RA Treatment Efficiency Tests
13.2.2.1. Salicylate Level Count Test Type
13.2.2.2. Muscle Enzyme Tests Type
13.2.2.3. Creatinine Test Type
13.3. Market Size (US$ Mn) Forecast By Test Type, 2017–2027
13.3.1. Serology Test Type
13.3.1.1. Erythrocyte Sedimentation Rate (ESR) Test Type
13.3.1.2. Rheumatoid Factor (RF) Test Type
13.3.1.3. Anti–cyclic Citrullinated Peptide (anti–CCP) Test Type
13.3.1.4. Antinuclear Antibody (ANA) Test Type
13.3.1.5. Uric Acid Test Type
13.3.1.6. Other Test Type
13.3.2. Monitoring RA Treatment Efficiency Tests
13.3.2.1. Salicylate Level Count Test Type
13.3.2.2. Muscle Enzyme Tests Type
13.3.2.3. Creatinine Test Type
13.4. Drivers and Restraints: Impact Analysis
13.5. Market Attractiveness Analysis By Technology

14. Global Rheumatoid Arthritis Diagnosis Tests Market Analysis 2012–2016 and Forecast 2017–2027, By End Users
14.1. Introduction/Key Findings
14.2. Historical Market Size (US$ Mn) Trend Analysis By End Users, 2012–2016
14.2.1. Diagnostics laboratories
14.2.1.1. Public Laboratories
14.2.1.2. Private Laboratories
14.2.2. Ambulatory Surgical Centers
14.2.3. Hospitals
14.3. Market Size (US$ Mn) Forecast By End Users, 2017–2027
14.3.1. Diagnostics laboratories
14.3.1.1. Public Laboratories
14.3.1.2. Private Laboratories
14.3.2. Ambulatory Surgical Centers
14.3.3. Hospitals
14.4. Drivers and Restraints: Impact Analysis
14.5. Market Attractiveness Analysis By Products

15. Global Rheumatoid Arthritis Diagnosis Tests Market Analysis 2012–2016 and Forecast 2017–2027
15.1. Market Size and Y-o-Y Growth
15.2. Absolute $ Opportunity
15.3. Value Chain

16. Research Methodology

List of Tables

Table 01: Global Rheumatoid Arthritis Diagnosis Test Market Pricing Analysis (US$) by Region, 2016
Table 02: North America Rheumatoid Arthritis Diagnosis Test Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country
Table 03: North America Rheumatoid Arthritis Diagnosis Test Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Test Type
Table 04: North America Rheumatoid Arthritis Diagnosis Test Market Volume (‘000 Units) Analysis-2012–2016 and Forecast 2017–2027, By Test Type
Table 05: North America Rheumatoid Arthritis Diagnosis Test Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By End User
Table 06: Latin America Rheumatoid Arthritis Diagnosis Test Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country
Table 07: Latin America Rheumatoid Arthritis Diagnosis Test Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Test Type
Table 08: Latin America Rheumatoid Arthritis Diagnosis Test Market Volume (‘000 Units) Analysis-2012–2016 and Forecast 2017–2027, By Test Type
Table 09: Latin America Rheumatoid Arthritis Diagnosis Test Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By End User
Table 10: Europe Rheumatoid Arthritis Diagnosis Test Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country
Table 11: Europe Rheumatoid Arthritis Diagnosis Test Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Test Type
Table 12: Europe Rheumatoid Arthritis Diagnosis Test Market Volume (‘000 Units) Analysis-2012–2016 and Forecast 2017–2027, By Test Type
Table 13: Europe Rheumatoid Arthritis Diagnosis Test Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By End User
Table 14: APAC Rheumatoid Arthritis Diagnosis Test Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country
Table 15: APAC Rheumatoid Arthritis Diagnosis Test Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Test Type
Table 16: APAC Rheumatoid Arthritis Diagnosis Test Market Volume (‘000 Units) Analysis-2012–2016 and Forecast 2017–2027, By Test Type
Table 17: APAC Rheumatoid Arthritis Diagnosis Test Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By End User
Table 18: MEA Rheumatoid Arthritis Diagnosis Test Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Country
Table 19: MEA Rheumatoid Arthritis Diagnosis Test Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By Test Type
Table 20: MEA Rheumatoid Arthritis Diagnosis Test Market Volume (‘000 Units) Analysis-2012–2016 and Forecast 2017–2027, By Test Type
Table 21: MEA Rheumatoid Arthritis Diagnosis Test Market Size (US$ Mn) Analysis-2012–2016 and Forecast 2017–2027, By End User
Table 22: Global Rheumatoid Arthritis Diagnosis Test Market Size (US$ Mn) 2012–2016 and Forecast 2017-2027 By Region
Table 23: Global Rheumatoid Arthritis Diagnosis Test Market Size (US$ Mn) 2012–2016 and Forecast 2017-2025 By Test Type
Table 24: Global Rheumatoid Arthritis Diagnosis Test Market Volume (Mn Units) Analysis-2012–2016 and Forecast 2017–2027, By Test Type
Table 25: Global Rheumatoid Arthritis Diagnosis Test Market Size (US$ Mn) 2012–2016 and Forecast 2017-2027 By End User